Association of the Prothrombin G20210A Mutation With Factor V Leiden in a Midwestern American Population
Open Access
- 1 August 2000
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 114 (2) , 272-275
- https://doi.org/10.1309/lqkg-f0d4-c6ff-fneh
Abstract
The prothrombin G20210A mutation has been identified as a risk factor for thrombosis. We studied the relationship between prothrombin G20210A and factor V Leiden mutations in patients with thrombophilia. The first 264 patients for whom these molecular diagnostic studies were requested at our institution were included in the study. For 116 of the 264 patients, additional coagulation test results were available in the laboratory database. The prothrombin G20210A mutation was found in 16 (6.1%) of the patients and the factor V Leiden mutation in 44 (16.7%). Of the 16 patients with the prothrombin G20210A mutation, 8 also carried factor V Leiden; this association was significant. In contrast, only 2 patients of the 116 with additional coagulation testing harbored more than 1 prothrombotic risk factor. These data support the hypothesis that thrombophilia is a multigenic disorder. Among unselected samples from a Midwestern population evaluated for thrombotic risk factors, the prevalence of factor V Leiden and prothrombin G20210A mutations are similar to those found in other populations in the Western world.Keywords
This publication has 11 references indexed in Scilit:
- The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin MutationNew England Journal of Medicine, 1999
- Coexistence of Factor V Leiden and Factor II A20210 Mutations and Recurrent Venous ThromboembolismThrombosis and Haemostasis, 1999
- The Risk of Recurrent Venous Thromboembolism in Carriers and Non-carriers of the G1691A Allele in the Coagulation Factor V Gene and the G20210A Allele in the Prothrombin GeneThrombosis and Haemostasis, 1999
- Increased Risk for Venous Thrombosis in Carriers of the Prothrombin G→A20210 Gene VariantAnnals of Internal Medicine, 1998
- High Risk of Cerebral-Vein Thrombosis in Carriers of a Prothrombin-Gene Mutation and in Users of Oral ContraceptivesNew England Journal of Medicine, 1998
- Geographic Distribution of the 20210 G to A Prothrombin VariantThrombosis and Haemostasis, 1998
- The Heterozygous 20210 G/A Prothrombin Genotype Is Associated With Early Venous Thrombosis in Inherited Thrombophilias and Is Not Increased in Frequency in Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′‐untranslated region of the prothrombin geneBritish Journal of Haematology, 1997
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957